Published in J Res Med Sci on June 01, 2013
Global scientific vision with local vigilance: renal transplantation in developing countries. Nephrourol Mon (2014) 0.75
M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med (2009) 11.81
Anti-phospholipase A₂ receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol (2011) 3.23
Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol (2011) 3.05
Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats. J Res Med Sci (2012) 2.66
Chronic kidney disease in children: A report from a tertiary care center over 11 years. J Nephropathol (2012) 2.10
Efficacy of Co-administration of Garlic Extract and Metformin for Prevention of Gentamicin-Renal Toxicity in Wistar Rats: A Biochemical Study. Int J Prev Med (2013) 1.90
Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int (2013) 1.84
New insights into membranous glomerulonephritis: from bench to bedside. Nephrol Dial Transplant (2011) 1.64
The epidemic of pediatric chronic kidney disease: the danger of skepticism. J Nephropathol (2012) 1.55
Diagnosis and natural course of membranous nephropathy. Semin Nephrol (2003) 1.52
Acute kidney injury: A pediatric experience over 10 years at a tertiary care center. J Nephropathol (2012) 1.43
Anti-PLA₂R antibodies in membranous nephropathy: ready for routine clinical practice? Neth J Med (2012) 1.42
Epidemiology of chronic kidney disease in children. J Nephropathol (2012) 1.33
Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy. Am J Transplant (2011) 1.25
Mammalian phospholipase A2: phospholipase A2 receptor. Biol Pharm Bull (2004) 1.18
Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats. Int J Prev Med (2013) 1.11
Histological patterns of idiopathic steroid resistant nephrotic syndrome in Egyptian children: A single centre study. J Nephropathol (2013) 1.11
Correlation of immunostaining findings with demographic data and variables of Oxford classification in IgA nephropathy. J Nephropathol (2013) 1.11
IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod Pathol (2013) 1.10
Frequency and clinicopathological characteristics of variants of primary focal segmental glomerulosclerosis in adults presenting with nephrotic syndrome. J Nephropathol (2013) 1.08
Imbalance of angiogenesis in diabetic complications: the mechanisms. Int J Prev Med (2012) 1.07
IgM nephropathy; can we still ignore it. J Nephropathol (2013) 1.04
Evaluation of damage index and its association with risk factors in patients with systemic lupus erythematosus. J Res Med Sci (2011) 1.02
Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: A report from Iranian population. J Nephropathol (2013) 0.94
Significance of immunohistochemical findings in Oxford classification of IgA nephropathy: The need for more validation studies. J Nephropathol (2013) 0.94
Association of serum uric acid with proteinuria in type 2 diabetic patients. J Res Med Sci (2013) 0.92
The effects of blocking Angiotensin receptors on early stages of diabetic nephropathy. Int J Prev Med (2012) 0.92
Detection of immunoglobulins and complement components in formalin fixed and paraffin embedded renal biopsy material by immunoflourescence technique. J Nephropathol (2012) 0.90
IgG4: a tantalizing link between causes of membranous glomerulonephritis and systemic disease. Kidney Int (2013) 0.89
Correlation of spot urine protein-creatinine ratio with 24-hour urinary protein in type 2 diabetes mellitus patients: A cross sectional study. J Res Med Sci (2011) 0.86
Steroid dependent and independent ocular findings in Iranian children with nephrotic syndrome. Int J Prev Med (2011) 0.86
Triggers, bullets and targets, puzzle of membranous nephropathy. Nephrourol Mon (2012) 0.86
Tubulointerstitial lupus nephritis. J Nephropathol (2013) 0.84
The first case of IgG4-related disease in Italy. J Nephropathol (2013) 0.84
Collapsing focal segmental glomerulosclerosis: Increasing the awareness. J Nephropathol (2012) 0.84
Kidney function in obese adolescents with or without metabolic syndrome in a nationally-representative sample of pediatric population: First report from the Middle East and North Africa: The CASPIAN-III Study: A Case-Control Study. J Res Med Sci (2013) 0.83
Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference. Int J Prev Med (2013) 0.83
Acute phase reactant dynamics and incidence of microvascular dysfunctions in type 2 diabetes mellitus. J Res Med Sci (2011) 0.81
Hidden face of lupus nephritis exposed: Isolated tubulointerstitial lupus nephritis. J Nephropathol (2013) 0.81
Commentary on: Is uric acid an indicator of metabolic syndrome in the first-degree relatives of patients with type 2 diabetes? J Res Med Sci (2013) 0.80
Idiopathic membranous nephropathy and anti-phospholipase A2 receptor antibodies. J Nephropathol (2013) 0.78
Chronic Kidney Disease Stages 3-5 in Iranian Children: Need for a School-based Screening Strategy: The CASPIAN-III Study. Int J Prev Med (2013) 0.77
Thrombotic Thrombocytopenic Purpura associated with Clopidogrel: a case report and review of the literature. J Res Med Sci (2011) 0.77
Assesment, treatment and prevention of atypical hemolytic uremic syndrome. Int J Prev Med (2013) 0.77
Does L-carnitine improve endothelial function in hemodialysis patients? J Res Med Sci (2012) 0.76
Correlation between B lymphocyte abnormality and disease activity in patients with idiopathic membranous nephropathy. J Int Med Res (2011) 0.76
Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats. J Res Med Sci (2012) 2.66
Efficacy of Co-administration of Garlic Extract and Metformin for Prevention of Gentamicin-Renal Toxicity in Wistar Rats: A Biochemical Study. Int J Prev Med (2013) 1.90
Sex differences in protective effect of recombinant human erythropoietin against cisplatin-induced nephrotoxicity in rats. Iran J Kidney Dis (2013) 1.67
Estrogen Abolishes Protective Effect of Erythropoietin against Cisplatin-Induced Nephrotoxicity in Ovariectomized Rats. ISRN Oncol (2012) 1.61
Multiple myeloma presenting as acute tubulointerstitial nephritis and normal serum protein electrophoresis. Iran J Kidney Dis (2012) 1.48
Mobile phone radiation interferes laboratory immunoenzymometric assays: Example chorionic gonadotropin assays. Pathophysiology (2012) 1.45
The protective role of endogenous nitric oxide donor (L-arginine) in cisplatin-induced nephrotoxicity: Gender related differences in rat model. J Res Med Sci (2011) 1.42
Administration of vitamin E and losartan as prophylaxes in cisplatin-induced nephrotoxicity model in rats. J Nephrol (2012) 1.23
Cisplatin nephrotoxicity may be sex related. Kidney Int (2013) 1.22
The role of angiotensin II receptor 1 (AT1) blockade in cisplatin-induced nephrotoxicity in rats: gender-related differences. Ren Fail (2012) 1.20
Vitamin E, Vitamin C, or Losartan Is Not Nephroprotectant against Cisplatin-Induced Nephrotoxicity in Presence of Estrogen in Ovariectomized Rat Model. Int J Nephrol (2012) 1.17
Protective Role of Silymarin and Deferoxamine Against Iron Dextran-induced Renal Iron Deposition in Male Rats. Int J Prev Med (2013) 1.11
R229Q polymorphism of NPHS2 gene in patients with late-onset steroid-resistance nephrotic syndrome: a preliminary study. Iran J Kidney Dis (2013) 1.09
Association of body mass index and serum vitamin D level in healthy Iranian adolescents. Endokrynol Pol (2012) 1.08
Evidence against protective role of sex hormone estrogen in Cisplatin-induced nephrotoxicity in ovarectomized rat model. Toxicol Int (2013) 1.08
Immunoglobulin A Nephropathy and Malaria falciparum Infection; a Rare Association. Iran J Public Health (2013) 1.03
Rare association of cutaneous vasculitis, IgA nephropathy and antiphospholipid antibody syndrome with tuberculous lymphadenitis. Clinics (Sao Paulo) (2013) 1.00
A model for prediction of cisplatin induced nephrotoxicity by kidney weight in experimental rats. J Res Med Sci (2013) 0.94
Inhibition of Nitric Oxide Synthase by L-NAME Promotes Cisplatin-Induced Nephrotoxicity in Male Rats. ISRN Toxicol (2013) 0.94
Suppressive impact of anethum graveolens consumption on biochemical risk factors of atherosclerosis in hypercholesterolemic rabbits. Int J Prev Med (2013) 0.92
Association of serum uric acid with proteinuria in type 2 diabetic patients. J Res Med Sci (2013) 0.92
Prevalence of Helicobacter pylori infection in maintenance hemodialysis patients with non-ulcer dyspepsia. Saudi J Kidney Dis Transpl (2009) 0.91
Correlation of serum magnesium with serum parathormone levels in patients on regular hemodialysis. Saudi J Kidney Dis Transpl (2006) 0.88
Association of Helicobacter pylori IgG antibody with various demographic and biochemical parameters in kidney transplant recipients. Saudi J Kidney Dis Transpl (2011) 0.88
Re: Erythropoietin ameliorates oxidative stress and tissue injury following renal ischemia/reperfusion in rat kidney and lung. Med Princ Pract (2013) 0.87
The Role of Magnesium Supplementation in Cisplatin-induced Nephrotoxicity in a Rat Model: No Nephroprotectant Effect. Int J Prev Med (2012) 0.86
A combination of vitamin C and losartan for cisplatin-induced nephrotoxicity in rats. Iran J Kidney Dis (2012) 0.86
Comment on: Clinical significance of IgG deposition in the glomerular mesangial area in patients with IgA nephropathy. Clin Exp Nephrol (2013) 0.85
Re: effect of erythropoietin on kidney allograft survival: early use after transplantation. Iran J Kidney Dis (2013) 0.83
C-Phycocyanin attenuates cisplatin-induced nephrotoxicity in mice. Ren Fail (2013) 0.83
Helicobacter pylori specific IgG antibody and serum magnesium in type-2 diabetes mellitus chronic kidney disease patients. Saudi J Kidney Dis Transpl (2011) 0.82
Comment on: preventive effect of Teucrium polium on learning and memory deficits in diabetic rats. Med Sci Monit Basic Res (2013) 0.81
Protective effects of subchronic caffeine administration on cisplatin induced urogenital toxicity in male mice. Indian J Exp Biol (2013) 0.81
Letter to the article: association of C1q deposition with renal outcomes in IgA nephropathy Clin Nephrol. 2013; 80: 98-104. Clin Nephrol (2014) 0.81
Massive proteinuria and acute glomerulonephritis picture in a patient with Familial Mediterranean fever and E148Q mutation. Iran J Kidney Dis (2014) 0.81
Re: Effect of alcoholic extract of Nigella sativa on cisplatin-induced toxicity in rat. Iran J Kidney Dis (2013) 0.81
Herbs and hazards: risk of aristolochic acid nephropathy in Iran. Iran J Kidney Dis (2015) 0.80
R: recombinant human erythropoietin reduces rhabdomyolysis-induced acute renal failure in rats. Injury (2013) 0.79
Acute tubular necrosis after renal allograft segmental infarction: the nephrotoxicity of necrotic material. Exp Clin Transplant (2008) 0.79
Comment on: Anti-Oxidative Stress Activity of Stachys lavandulifolia Aqueous Extract in Humans. Cell J (2013) 0.78
Ameliorative Effect of Green Tea Against Contrast-induced Renal Tubular Cell Injury. Iran J Kidney Dis (2015) 0.78
Effect of garlic extract on blood glucose level and lipid profile in normal and alloxan diabetic rabbits. Adv Clin Exp Med (2013) 0.76
Correlation of serum parathormone with hypertension in chronic renal failure patients treated with hemodialysis. Saudi J Kidney Dis Transpl (2007) 0.76
Comment on: Protective Role of Recombinant Human Erythropoietin in Kidney and Lung Injury Following Renal Bilateral Ischemia-reperfusion in Rat Model. Int J Prev Med (2013) 0.76
Comment on "Hepatic-associated immunoglobulin a nephropathy in a child with liver cirrhosis and portal hypertension". Saudi J Gastroenterol (2014) 0.75
Comment on "Carbamylated erythropoietin ameliorates cyclosporine nephropathy without stimulating erythropoiesis". Cell Transplant (2013) 0.75
Re: association between serum magnesium and risk factors of cardiovascular disease in hemodialysis patients. Iran J Kidney Dis (2013) 0.75
Erythropoietin and renal protection. Daru (2013) 0.75
Prevention of hypomagnesemia in diabetes patients. Int J Prev Med (2013) 0.75
Re: Atypical clinical course of antineutrophil cytoplasmic autoantibodies-associated vasculitis. Iran J Kidney Dis (2013) 0.75
Aggravation of immunoglobulin a nephropathy by hyperuricemia: a mini-review on current findings and new concepts. Iran J Kidney Dis (2014) 0.75
Association between white blood cell count and levels of serum homocysteine in end-stage renal failure patients treating with hemodialysis. J Ayub Med Coll Abbottabad (2006) 0.75
Renal vascular lesions in lupus nephritis: A need for further characterization of vasculopathy. Saudi J Kidney Dis Transpl (2015) 0.75